Global Cell Engineering Service Market Growth (Status and Outlook) 2024-2030

Global Cell Engineering Service Market Growth (Status and Outlook) 2024-2030

Cell engineering services refer to professional services for transforming, cultivating and optimizing cells through a series of biotechnological means, including gene editing, cell line development, cell culture, phenotypic transformation, differentiation and reprogramming. Its purpose is to provide customized cell models and products for scientific research, drug development and treatment, supporting all stages from basic research to clinical application. These services have a wide range of applications in the fields of biopharmaceuticals, regenerative medicine and cell therapy, and have promoted the innovation and development of the life science and pharmaceutical industries.

The global Cell Engineering Service market size is projected to grow from US$ 1115 million in 2024 to US$ 1852 million in 2030; it is expected to grow at a CAGR of 8.8% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Cell Engineering Service Industry Forecast” looks at past sales and reviews total world Cell Engineering Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Engineering Service sales for 2023 through 2029. With Cell Engineering Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Engineering Service industry.

This Insight Report provides a comprehensive analysis of the global Cell Engineering Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Engineering Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Engineering Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Engineering Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Engineering Service.

Cell engineering services are increasingly becoming a core driving force in the field of biopharmaceuticals and regenerative medicine. With the continuous advancement of gene editing technology and cell culture technology, these services have not only accelerated the process of new drug development and personalized treatment, but also promoted the development of cutting-edge fields such as cell therapy and tissue engineering. In the future, cell engineering services will play a more critical role in precision medicine and innovative treatment plans, providing more effective solutions for dealing with complex diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Engineering Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Gene Editing
Cell Line Development
Others

Segmentation by Application:
Medical Industry
Scientific Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Gene Editing
Cell Line Development
Others

Segmentation by Application:
Medical Industry
Scientific Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Portal Biotechnologies
Lonza Group
Thermo Fisher Scientific
Sartorius
GenScript
Metagenomi
CorrectSequence Therapeutics
Eddie Gene

Please note: The report will take approximately 2 business days to prepare and deliver.